WATSON 746 (Clonazepam 0.5 mg)
Pill imprint WATSON 746 has been identified as Clonazepam 0.5 mg.
Clonazepam is used in the treatment of anxiety; bipolar disorder; panic disorder; benzodiazepine withdrawal; insomnia (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Clonazepam 0.5 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Images for WATSON 746 (Clonazepam 0.5 mg)
- 0.5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Benzodiazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- docusate sodium
sodium starch glycolate
D&C Yellow No. 10 Aluminium Lake
|NDC Code||Manufacturer / Repackager|
|55289-0599||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.